Fischer C, Chen S-S, Nimmerfroh J, Eugster A, Stücheli S, Schultheiß C, Widmer C, Heim D, Kasenda B, Passweg J, Kobold S, Egli L, Coianiz N, Chijioke O, Chiorazzi N, Follo M, Läubli H, Peipp M, Binder M. IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia. haematol [Internet]. 2020Sep.10 [cited 2025Nov.12];. Available from: https://haematologica.org/article/view/12266